Viewing Study NCT01693692


Ignite Creation Date: 2025-12-24 @ 3:24 PM
Ignite Modification Date: 2026-01-24 @ 9:42 PM
Study NCT ID: NCT01693692
Status: COMPLETED
Last Update Posted: 2022-03-04
First Post: 2012-09-20
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Phase 2 Study of TD-9855 to Treat Fibromyalgia
Sponsor: Theravance Biopharma
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Fibromyalgia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Fibromyalgia View